This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:physicians:concerns [05.26.2019] – [Recorded success rates] sallieq | home:physicians:concerns [06.01.2019] – [Physicians' concerns about the Marshall Protocol] sallieq | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Physicians' | ====== Physicians' | ||
+ | |||
+ | < | ||
Over the years, physicians have voiced various concerns about the Marshall Protocol, concerns ranging from the safety of higher doses of olmesartan (Benicar) to concerns about long-term antibiotic use. The Autoimmunity Research Foundation has assembled articles, well-grounded in scientific research, which address these concerns. Physicians who choose to use and administer the MP do so on the basis of the [[home: | Over the years, physicians have voiced various concerns about the Marshall Protocol, concerns ranging from the safety of higher doses of olmesartan (Benicar) to concerns about long-term antibiotic use. The Autoimmunity Research Foundation has assembled articles, well-grounded in scientific research, which address these concerns. Physicians who choose to use and administer the MP do so on the basis of the [[home: | ||
Line 114: | Line 116: | ||
{{tag> | {{tag> | ||
+ | |||
+ | [[home: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||